Scientists have discovered a promising new therapy for resistant high blood pressure, leading to a 15-point drop in systolic levels. Researchers at the University of California, San Diego School of Medicine have identified a potential new treatment for individuals with uncontrolled or treatment-resistant hypertension, a condition commonly referred to as high blood pressure. The investigational drug, lorundrostat, showed encouraging results in a recent clinical trial. Published in the New England Journal of Medicine, the study found that participants who received lorundrostat experienced an average 15-point reduction in systolic blood pressure, the upper number in a blood pressure reading, compared to...